Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2014
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancerJ Oldenburg, J Aparicio, J Beyer, et al.
International Journal of Cancer|December 24, 2015
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancerSergey A Dyshlovoy, Ekaterina S Menchinskaya, Simone Venz, et al.
Breast (Edinburgh, Scotland)|July 13, 2024
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancerEleonora Pagan, Monica Ruggeri, Nadia Bianco, et al.
Science Advances|July 22, 2021
Linking the FTO obesity rs1421085 variant circuitry to cellular, metabolic, and organismal phenotypes in vivoSamantha Laber, Sara Forcisi, Liz Bentley, et al.
Cancer Research|May 3, 2003
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumorsLeendert H J Looijenga, Hans Stoop, Hubert P J C de Leeuw, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Loss of RREB1 reduces adipogenesis and improves insulin sensitivity in mouse and human adipocytesGrace Z Yu, Nicole A J Krentz, Liz Bentley, et al.
Oncotarget|September 15, 2016
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Winfried H Alsdorf, et al.
Nature Metabolism|May 30, 2023
A non-coding variant linked to metabolic obesity with normal weight affects actin remodelling in subcutaneous adipocytesViktoria Glunk, Samantha Laber, Nasa Sinnott-Armstrong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2018
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-upF Honecker, J Aparicio, D Berney, et al.
Pageof 24